Psychostimulants and monoamine transporters: Upsetting the balance

Current Opinion in Pharmacology

Volumn 5, Issue 1, 2005, Pages 94-100

  Elliott, J Martin ^a   Beveridge, Thomas J R ^b  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; COCAINE; DESIPRAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; ION CHANNEL; METHYLPHENIDATE; NISOXETINE; NORADRENALIN TRANSPORTER; PHOSPHATASE; PHOSPHOTRANSFERASE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN TRANSPORTER; SERTRALINE; VANOXERINE; VESICULAR MONOAMINE TRANSPORTER;

ADDICTION; AMINE TRANSPORT; ATTENTION DEFICIT DISORDER; BINDING SITE; CELL MEMBRANE TRANSPORT; DEPRESSION; EXOCYTOSIS; HUMAN; MOLECULAR INTERACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW;

AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOGENIC MONOAMINES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS;

EID: 12344306259     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.09.005     Document Type: Review

References (50)

1. G. Rudnick J. Clark From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters Biochim Biophys Acta 1144 1993 249-263
2. R.D. Blakely L.J. De Felice H.C. Hartzell Molecular physiology of norepinephrine and serotonin transporters J Exp Biol 196 1994 263-281
3. J.W. Schwartz R.D. Blakely L.J. DeFelice Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate J Biol Chem 278 2003 9768-9777
4. M.J. Nirenberg J. Chan A. Pohorille R.A. Vaughan G.R. Uhl M.J. Kuhar V.M. Pickel The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens J Neurosci 17 1997 6899-6907
5. V.M. Pickel J. Chan Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens J Neurosci 19 1999 7356-7366
6. R.R. Gainetdinov M.G. Caron Monoamine transporters: From genes to behavior Annu Rev Pharmacol Toxicol 43 2003 261-284
7. G.E. Torres R.R. Gainetdinov M.G. Caron Plasma membrane monoamine transporters: Structure, regulation and function Nat Rev Neurosci 4 2003 13-25
8. R. Bosse F. Fumagalli M. Jaber B. Giros R.R. Gainetdinov W.C. Wetsel C. Missale M.G. Caron Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter Neuron 19 1997 127-138
9. H. Gu S.C. Wall G. Rudnick Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence J Biol Chem 269 1994 7124-7130
10. S.L. Ingram B.M. Prasad S.G. Amara Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons Nat Neurosci 5 2002 971-978
11. M.W. Quick Regulating the conducting states of a mammalian serotonin transporter Neuron 40 2003 537-549
12. D. Sulzer A. Galli Dopamine transport currents are promoted from curiosity to physiology Trends Neurosci 26 2003 173-176
13. H.H. Sitte S. Huck H. Reither S. Boehm E.A. Singer C. Pifl Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter J Neurochem 71 1998 1289-1297
14. H. Khoshbouei H. Wang J.D. Lechleiter J.A. Javitch A. Galli Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism J Biol Chem 278 2003 12070-12077
15. 2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter Mol Pharmacol 66 2004 137-143
16. M.E. Gnegy The effect of phosphorylation on amphetamine-mediated outward transport Eur J Pharmacol 479 2003 83-91
17. B.H. Falkenburger K.L. Barstow I.M. Mintz Dendrodendritic inhibition through reversal of dopamine transport Science 293 2001 2465-2470
18. S. Cragg M.E. Rice S.A. Greenfield Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum J Neurophysiol 77 1997 863-873
19. O.V. Mortensen S.G. Amara Dynamic regulation of the dopamine transporter Eur J Pharmacol 479 2003 159-170
20. R.A. Vaughan Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters J Pharmacol Exp Ther 310 2004 1-7
21. S. Benmansour W.A. Owens M. Cecchi D.A. Morilak A. Frazer Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter J Neurosci 22 2002 6766-6772
22. S. Benmansour A.V. Altamirano D.J. Jones T.A. Sanchez G.G. Gould M.C. Pardon D.A. Morilak A. Frazer Regulation of the norepinephrine transporter by chronic administration of antidepressants Biol Psychiatry 55 2004 313-316
23. S. Ramamoorthy R.D. Blakely Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants Science 285 1999 763-766
24. D. Weinshenker S.S. White M.A. Javors R.D. Palmiter P. Szot Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo Brain Res 946 2002 239-246
25. C. Granas J. Ferrer C.J. Loland J.A. Javitch U. Gether N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization J Biol Chem 278 2003 4990-5000
26. K.M. Kahlig J.A. Javitch A. Galli Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier J Biol Chem 279 2004 8966-8975
27. J.A. Schmid H. Just H.H. Sitte Impact of oligomerization on the function of the human serotonin transporter Biochem Soc Trans 29 2001 732-736
28. T. Sorkina S. Doolen E. Galperin N.R. Zahniser A. Sorkin Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy J Biol Chem 278 2003 28274-28283
29. A.M. Kocabas G. Rudnick F. Kilic Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters J Neurochem 85 2003 1513-1520
30. A.R. Green A.O. Mechan J.M. Elliott E. O'Shea M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') Pharmacol Rev 55 2003 463-508
31. M.I. Colado E. O'Shea A.R. Green Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function Psychopharmacology (Berl) 173 2004 249-263
32. H. Khoshbouei N. Sen B. Guptaroy L. Johnson D. Lund M.E. Gnegy A. Galli J.A. Javitch N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux PLoS Biol 2 2004 E78
33. E. Carboni C. Spielewoy C. Vacca M. Nosten-Bertrand B. Giros G. Di Chiara Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene J Neurosci 21 2001 RC141:1-4
34. E.A. Budygin M.S. Brodie T.D. Sotnikova Y. Mateo C.E. John M. Cyr R.R. Gainetdinov S.R. Jones Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine Proc Natl Acad Sci USA 101 2004 7781-7786
35. A.E. Fleckenstein J.W. Gibb G.R. Hanson Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity Eur J Pharmacol 406 2000 1-13
36. A.E. Fleckenstein G.R. Hanson Impact of psychostimulants on vesicular monoamine transporter function Eur J Pharmacol 479 2003 283-289
37. F. Fumagalli R.R. Gainetdinov Y.M. Wang K.J. Valenzano G.W. Miller M.G. Caron Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice J Neurosci 19 1999 2424-2431
38. S.N. Saldana E.L. Barker Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake Neurosci Lett 354 2004 209-212
39. A. Kanthasamy J.E. Sprague J.R. Shotwell D.E. Nichols Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum Neuroscience 114 2002 917-924
40. B.A. Bennett C.H. Wichems C.K. Hollingsworth H.M. Davies C. Thornley T. Sexton S.R. Childers Novel 2-substituted cocaine analogs: Uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain J Pharmacol Exp Ther 272 1995 1176-1186
41. H. Hastrup N. Sen J.A. Javitch The human dopamine transporter forms a tetramer in the plasma membrane: Cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs J Biol Chem 278 2003 45045-45048
42. W. Wang M.S. Sonders O.T. Ukairo H. Scott M.K. Kloetzel C.K. Surratt Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter Mol Pharmacol 64 2003 430-439
43. B.A. Rocha F. Fumagalli R.R. Gainetdinov S.R. Jones R. Ator B. Giros G.W. Miller M.G. Caron Cocaine self-administration in dopamine-transporter knockout mice Nat Neurosci 1 1998 132-137
44. Y. Mateo E.A. Budygin C.E. John S.R. Jones Role of serotonin in cocaine effects in mice with reduced dopamine transporter function Proc Natl Acad Sci USA 101 2004 372-377
45. F.S. Hall X.F. Li I. Sora F. Xu M. Caron K.P. Lesch D.L. Murphy G.R. Uhl Cocaine mechanisms: Enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions Neuroscience 115 2002 153-161
46. I. Sora F.S. Hall A.M. Andrews M. Itokawa X.F. Li H.B. Wei C. Wichems K.P. Lesch D.L. Murphy G.R. Uhl Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc Natl Acad Sci USA 98 2001 5300-5305
47. K.P. Lindsey K.M. Wilcox J.R. Votaw M.M. Goodman C. Plisson F.I. Carroll K.C. Rice L.L. Howell Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: Relationship to transporter occupancy determined by positron emission tomography neuroimaging J Pharmacol Exp Ther 309 2004 959-969
48. J.R. Cashman Biocatalysts in detoxication of drugs of abuse NIDA Res Monogr 173 1997 225-258
49. M.R. Carrera G.F. Kaufmann J.M. Mee M.M. Meijler G.F. Koob K.D. Janda Treating cocaine addiction with viruses Proc Natl Acad Sci USA 101 2004 10416-10421
50. M. Haney T.R. Kosten Therapeutic vaccines for substance dependence Expert Rev Vaccines 3 2004 11-18